cilastatin has been researched along with Infant, Premature, Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böswald, M; Döbig, C; Guggenbichler, JP; Kändler, C; Krüger, C; Scharf, J; Soergel, F; Zink, S | 1 |
Fujimoto, T; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S | 1 |
Aufrant, C; Bompard, Y; Chastel, A; Gantzer, A; Lambert, T; Voinnesson, A | 1 |
Akita, H; Ishizuka, Y; Iwata, S; Oikawa, T; Saito, N; Sato, Y; Sunakawa, K | 1 |
Hori, M; Joh, K; Sugita, M; Toyonaga, Y | 1 |
1 trial(s) available for cilastatin and Infant, Premature, Diseases
Article | Year |
---|---|
[Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Male; Multicenter Studies as Topic | 1989 |
4 other study(ies) available for cilastatin and Infant, Premature, Diseases
Article | Year |
---|---|
Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.
Topics: Bacteremia; Cilastatin; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Prognosis; Protease Inhibitors; Retrospective Studies; Severity of Illness Index; Survival Rate; Thienamycins | 1999 |
[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Sepsis; Thienamycins | 1988 |
[Bacteriological and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Topics: Bacteria; Bacterial Infections; Blood Coagulation; Blood Coagulation Tests; Cilastatin; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Male; Streptococcus agalactiae | 1988 |
[Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
Topics: Age Factors; Bacterial Infections; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Male | 1988 |